| Literature DB >> 35203874 |
Fabrizio Bertelloni1, Giulia Cagnoli1, Barbara Turchi1, Valentina Virginia Ebani1.
Abstract
Salmonellosis is one of the most important zoonoses in Europe and the world. Human infection may evolve in severe clinical diseases, with the need for hospitalization and antimicrobial treatment. Colistin is now considered an important antimicrobial to treat infections from multidrug- resistant Gram-negative bacteria, but the spreading of mobile colistin-resistance (mcr) genes has limited this option. We aimed to evaluate colistin minimum inhibitory concentration and the presence of mcr (mcr-1 to mcr-9) genes in 236 Salmonella isolates previously collected from different animals and the environment between 2000 and 2020. Overall, 17.79% of isolates were resistant to colistin; no differences were observed in relation to years of isolation (2000-2005, 2009-2014, and 2015-2020), Salmonella enterica subspecies (enterica, salamae, diarizonae, and houtenae), origin of samples (domestic animals, wildlife, and environment), or animal category (birds, mammals, and reptiles); only recently isolated strains from houseflies showed the most resistance. Few isolates (5.93%) scored positive for mcr genes, in particular for mcr-1, mcr-2, mcr-4, mcr-6, and mcr-8; furthermore, only 2.54% of isolates were mcr-positive and colistin-resistant. Detected resistance to colistin was equally distributed among all examined Salmonella isolates and not always related to the presence of mcr genes.Entities:
Keywords: Salmonella; animals; colistin resistance; mcr
Year: 2022 PMID: 35203874 PMCID: PMC8868313 DOI: 10.3390/antibiotics11020272
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Distribution of the tested Salmonella strains in relation to minimum inhibitory concentration (MIC) values and years of isolation.
| Years of Isolation | MIC Values (µg/mL) | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | >256 | ||
| 2000–2005 | 30 | 26 | 39 | 14 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 112 |
| 2009–2014 | 16 | 26 | 19 | 10 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 72 |
| 2015–2020 | 12 | 8 | 16 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 50 |
| Total | 58 | 61 | 75 | 33 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | 58 |
Distribution of the tested Salmonella strains in relation to minimum inhibitory concentration (MIC) values and origin of samples.
| MIC Values (µg/mL) | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | >256 | ||
| Domestic animals | 43 | 48 | 54 | 22 | 1 | 1 | 0 | 0 | 0 | 1 | 4 | 174 |
| Wild animals | 14 | 10 | 15 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 51 |
| Environment | 1 | 3 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| Total | 58 | 61 | 75 | 33 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | 236 |
Distribution of the tested Salmonella strains in relation to minimum inhibitory concentration (MIC) values and animal categories.
| MIC Values (µg/mL) | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | >256 | ||
| Arthropoda | 3 | 1 | 4 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
| Birds | 10 | 16 | 14 | 10 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 51 |
| Mammals | 14 | 15 | 20 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 63 |
| Reptiles | 30 | 26 | 31 | 9 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 98 |
| Environment/ | 1 | 3 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| Total | 58 | 61 | 75 | 33 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | 236 |
Distribution of the tested Salmonella strains in relation to minimum inhibitory concentration (MIC) values and subspecies.
| Subspecies | MIC Values (µg/mL) | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | >256 | ||
|
| 48 | 59 | 61 | 30 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 202 |
|
| 3 | 0 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
|
| 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 |
|
| 3 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 14 |
| R phase | 1 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Total | 58 | 61 | 75 | 33 | 1 | 1 | 0 | 0 | 0 | 1 | 6 | 236 |
Minimum inhibitory concentration (MIC) values obtained for Salmonella serovars most frequently detected in human infections in EU between 2015 and 2019.
| Serovar | MIC Values (µg/mL) | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | >256 | ||
| Derby | 4 | 8 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 16 |
| Enteritidis | 0 | 3 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
| Infantis | 1 | 2 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Newport | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| TMV | 0 | 5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Typhimurium | 9 | 5 | 9 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 29 |
Legend: TMV = Typhimurium monophasic variant.
Detailed information about the mcr-positive Salmonella isolates.
| Isolate | Subspecies | Serovar | Animal | Sample | Year | MIC |
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| S356 |
| 1,40:z4,z23:- | Donkey | Organs | 2019 | >256 | - | + | - | - | - |
| S358 |
| 1,40:z4,z23:- | Sheep | Organs | 2019 | >256 | - | + | - | - | - |
| S374 |
| Napoli | Housefly | 2019 | 4 | - | + | + | - | - | |
| S375 | R phase | Housefly | 2019 | 4 | - | - | + | - | - | ||
| S378 | R phase | Housefly | 2019 | 4 | - | - | + | - | - | ||
| S386 |
| 50:r:1,5,7 | Wild boar | Feces | 2019 | >256 | + | - | - | - | - |
| R43 |
| Trimndon | Reptile | Feces | 2002 | ≤0.5 | - | - | - | + | - |
| R108 |
| Memphis | Reptile | Feces | 2002 | ≤0.5 | - | + | - | - | - |
| R164 |
| 44:z4,z23:- | Reptile | Feces | 2002 | 2 | - | - | - | - | + |
| R161 |
| 44:z4,z23:- | Reptile | Feces | 2002 | 2 | - | + | - | - | - |
| R173 |
| Senftenberg | Reptile | Feces | 2002 | ≤0.5 | - | - | - | - | + |
| R300 |
| 50:z:z52 | Reptile | Feces | 2002 | 1 | + | - | + | - | - |
| R112 |
| 18:z36,z23:- | Reptile | Feces | 2002 | ≤0.5 | - | + | - | - | - |
| R126 |
| 48:z4,z23:- | Reptile | Feces | 2002 | 2 | - | + | - | - | - |
| Total | 2 | 7 | 4 | 1 | 2 | ||||||
Primers and protocols employed in PCR assays.
| Target Gene | Primer Name | Sequence (5′-3′) | Expected | Protocols | References | |
|---|---|---|---|---|---|---|
| Multiplex 1 |
| mcr1_320bp_fw | AGTCCGTTTGTTCTTGTGGC | 320 | Initial denaturation at 95 °C for 10 min, | [ |
| mcr1_320bp_rev | AGATCCTTGGTCTCGGCTTG | |||||
|
| mcr2_700bp_fw | CAAGTGTGTTGGTCGCAGTT | 715 | |||
| mcr2_700bp_rev | TCTAGCCCGACAAGCATACC | |||||
|
| mcr3_900bp_fw | AAATAAAAATTGTTCCGCTTATG | 929 | |||
| mcr3_900bp_rev | AATGGAGATCCCCGTTTTT | |||||
|
| mcr4_1100bp_fw | TCACTTTCATCACTGCGTTG | 1116 | |||
| mcr4_1100bp_rev | TTGGTCCATGACTACCAATG | |||||
|
| MCR5_fw | ATGCGGTTGTCTGCATTTATC | 1644 | |||
| MCR5_rev | TCATTGTGGTTGTCCTTTTCTG | |||||
| Multiplex 2 |
| mcr-6_mp_fw | AGCTATGTCAATCCCGTGAT | 252 | Initial denaturation at 95 °C for 10 min, | [ |
| mcr-6_mp_rev | ATTGGCTAGGTTGTCAATC | |||||
|
| mcr-7_mp_fw | GCCCTTCTTTTCGTTGTT | 551 | |||
| mcr-7_mp_rev | GGTTGGTCTCTTTCTCGT | |||||
|
| mcr-8_mp_fw | TCAACAATTCTACAAAGCGTG | 856 | |||
| mcr-8_mp_rev | AATGCTGCGCGAATGAAG | |||||
|
| mcr-9_mp_fw | TTCCCTTTGTTCTGGTTG | 1011 | |||
| mcr-9_mp_rev | GCAGGTAATAAGTCGGTC |